glp-1 long term safety Long-Term Effects Of Medications: What You Should Know long term use of glp

Hepatic: Recommendations 9.12 and 9.13a establish GLP-1 RA as preferred therapy for MASH in the context of type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD)

Elsevier Health Sciences

Specifically, researchers have made comments about their observation of outcomes in research models, such as increased [darkened] pigmentation in the face, upper body, and buttock in experimental settings

Anecdotally, lots of people who take GLP-1 medication agonists report that the "food noise" in their head really quiets down, minimizing cravings

This often restores first-phase insulin secretion and production, helping to prevent blood sugar spikes after meals